New five in one vaccine for infants in US
The US Food and Drug Administration has approved a five-in-one combination vaccine, which could result in 24 million fewer injections a year for US infants, the vaccine's maker GlaxoSmithKline said.
Related Content
- Sub national variation and inequalities in under-five mortality in Kenya since 1965
- Global vaccination targets ‘off-track’ warns WHO
- Government to introduce vaccine to reduce under-5 mortality rate
- Life expectancy up by 5 yrs in a decade
- Pentavalent vaccine to be introduced today
- India leads in rotavirus infection deaths: Lancet